A study by consulting firm Accenture shows that patients not only expect digital outreach, but that their desire to be engaged is consistently being ignored.
Famous from his reality show, "The Osbournes," Jack narrates his life with MS in a web documentary series.
Although doctors still like sales reps, Capgemini and Quantia's researchers find their appeal is on the decline, while digital is on the rise. While age is a factor, it's the workplace that's shaping physician preferences.
Despite a possible government standoff, exchanges are coming, as is a proffered rebrand; Amgen signs a university deal in China; Pakistan seeks to rein in pharma; digital marketing is on the rise, research shows
The drug maker, through its venture fund, took a controlling interest in the digital physician marketing firm.
The drug maker's broadcast-heavy "OAB reality" campaign stresses the emotional toll on women.
The duo whose nonprofit served as neutral ground for getting FDA and industry talking about digital marketing is starting a for-profit research and advisory firm.
Merck came late to the iPad party, but the company has made up the distance by releasing a global template for details using the device.
Pharmas need to start fine-tuning paid search and producing "liquid content" that moves fluidly between screens, said Google's David Blair at our first MM&M Skill Sets Live session
Pharmas are spending far less on reprints and far more on digital promotion to physicians and other healthcare professionals, according to a healthcare media buying specialist.
Gwee, who pioneered pharma social media at Vertex before moving onto the agency side, is tasked with integrating digital and social strategies across the marketing and PR network's 14 agencies.
At first blush, Accenture's survey of pharma execs looks like more bad news for sales forces, but the firm tells MM&M that the sales overhauls are about more than reducing headcounts.
Epocrates, now under new management, has jettisoned its QuickRecruit offering as it focuses its market research business on pharmas.
Deploying digital frameworks across large pharmaceutical organizations is a tricky business the world over, as execs convening in Barcelona can tell you. Securing local buy-in is essential to a successful multichannel roll-out.
It's not even in beta yet, but Facebook's Graph Search is sending tremors through the advertising landscape. For pharmas, the arrival of social search promises great opportunity -- and many perils.
From tech shifts to talent, and from emerging markets to engaging with social media, agency execs offer their predictions for what the New Year will bring.
Pharma's med/legal/regulatory (MLR) teams, managers of risk and so often the scapegoats for creating roadblocks to digital innovation, were discussed in a much friendlier light by digital marketers at last week's ExL Digital Pharma East conference in Philadelphia.
Publicis is uniting two of its digital agencies as it seeks to keep the pure-play "e" units competitive.
The fan base of the AMA's publishing arm grew 115% in the second quarter.
Three out of five doctors are now using technology to better communicate with patients, a MedPage Today survey has found, and two-fifths say patients are generally more informed than they were five years ago.
There have been multiple promises by pharma to change its sales and marketing approach. Booz & Co. partner Danielle Rollmann says the time for promises is over, and action needs to happen, particularly in the digital space. Now.
Novartis named Brian McNamara as division head of OTC, replacing J&J veteran Naomi Kelman, who spent a year in the role.
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.